A Pharmacological Review of Bioactive Constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch: Review of P. lactiflora Pallas and P. veitchii Lynch
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The roots of two peony species, Paeonia lactiflora Pallas and Paeonia veitchii Lynch are routinely referred to as either chishao () or baishao (). This paper reviews the botanical origins and traditional medicinal usage of each species, as well as pharmacological like activity of their constituents. A search of herbal pharmacological encyclopaedia, PubChem and PubMed databases identified their known constituents. The biological data for these constituents were evaluated and classified according to pharmacological-like activity, with emphasis on compounds of greatest concentration and bioavailability. It was found that P. lactiflora and P. veitchii have some common compounds; however, their phytochemical bioavailability varies. Furthermore, a larger number of compounds have been identified in P. lactiflora. These have greater potential for antiinflammatory, antiviral, antibacterial and antioxidant therapeutic activity compared with P. veitchii. However, evidence indicates both species are similarly indicated for antiviral and glycaemic activity. Major compounds of each are classified as flavonoids, hydrolysable tannins (polyphenols) and monoterpene glycosides. The evidence suggests both species, when administered in entire botanical form, have an excellent safety profile; however, constituent toxicity risk evidence is limited, requiring further investigation. Although experiments show many compounds have biological activity, further investigation of their therapeutic potential is needed. Copyright © 2016 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · cited 1×
“Such APP reduction may have therapeutic potential for dementia, as APP generates beta amyloid (Aβ) peptide that forms the characteristic Alzheimer’s disease amyloid plaques (O’Brien and Wong, 2011).”
BackgroundRole of nitric oxide in inflammatory diseases
Sharma, J. N., Al-Omran, A., & Parvathy, S. S. (2007) · Inflammopharmacology · doi:10.1007/s10787-007-0013-x · Cited by 1,403
Vidarabine versus Acyclovir Therapy in Herpes Simplex Encephalitis
Whitley, R. J., Alford, C. A., Hirsch, M. S., Schooley, R. T., Luby, J. P., Aoki, F. Y., Hanley, D., Nahmias, A. J., Soong, S.-J., & The NIAID Collaborative Antiviral Study Group* (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140303 · Cited by 896 · cited 2×
“Found in P. veitchii, cellular study of tellimagrandin II (eugeniin 20–30μg/mL) has shown it inhibits HSV with a greater therapeutic index than the clinical HSV drug vidarabine (Whitley et al., 1986).”
BackgroundMicroRNA-21: From Cancer to Cardiovascular Disease
Jazbutyte, V., & Thum, T. (2010) · Current Drug Targets · doi:10.2174/138945010791591403 · Cited by 226
Metadata
- Authors
- Parker, S., May, B., Zhang, C., Zhang, A. L., Lu, C., & Xue, C. C.
- Venue
- Phytotherapy Research
- Publisher
- Wiley
- Published
- 2016-06-09
- Volume
- 30
- Issue
- 9
- Pages
- 1445-1473
- ISSN
- 0951-418X (ISSN-L)
- OpenAlex
- W2415017536
- Cited by
- 160
- References
- 4
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Pharmacological Review of Bioactive Constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch: Review of P. lactiflora Pallas and P. veitchii Lynch. https://app.cochat.ai/papers/10.1002/ptr.5653
- The paper
- Parker, S., May, B., Zhang, C., Zhang, A. L., Lu, C., & Xue, C. C. (2016). A Pharmacological Review of Bioactive Constituents of Paeonia lactiflora Pallas and Paeonia veitchii Lynch: Review of P. lactiflora Pallas and P. veitchii Lynch. Phytotherapy Research. https://doi.org/10.1002/ptr.5653
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.